Solid Tumors
A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies (SGN35-033)
- Details
ClinicalTrials.gov ID:
NCT04609566
Diagnosis Type:
NA
USOR Number:
- Address
520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001